Action BLT BENITEC BIOPHARMA LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Benitec Biopharma Limited Australian S.E.

Actions

BLT

AU000000BLT8

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors
Benitec Biopharma Inc. Announces Appointment of Kishen Mehta to Its Board of Directors
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell 3000E Index
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Microcap Index
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Microcap Value Index
Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell 3000E Value Index
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
Benitec Biopharma : Releases Third Quarter 2024 Financial Results and Provides Operational Update - Form 8-K
Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Benitec Biopharma to Participate in the Citizens JMP Life Science Conference
Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading
Top Midday Gainers
Top Premarket Gainers
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Benitec Biopharma Inc. Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
Benitec Biopharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BNTC
  4. Action BLT
  5. Actualités Benitec Biopharma Limited
  6. Autres langues